|
Phase 3 Pharmacokinetics (PK) and Safety Study of Posaconazole (POS) IV in Patients (Pts) at Risk for Invasive Fungal Infection (IFI) (click for details) |
|
|
|
Anti-biofilm Efficacy of Liposomal Amphotericin B and Echinocandin Catheter Lock Solutions against Candida Species (click for details) |
|
|
|
Activity of Isavuconazole, Amphotericin B, and Micafungin Alone and in Combination against Exserohilum rostratum (click for details) |
|
|
|
Blood Concentrations and Toxicity of Voriconazole and its Metabolites (click for details) |
|
|
|
Efficacy and Safety of Micafungin as Antifungal Prophylaxis in High-risk Liver Transplantation (click for details) |
|
|
|
Clinical Pharmacodynamic (PD) Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization (click for details) |
|
|
|
Posaconazole and Caspofungin Antifungal Susceptibility of Molecularly Confirmed Schizophyllum commune, an Emerging Basidiomycete Fungus (click for details) |
|
|
|
Isavuconazole Susceptibility in Triazole Resistant Aspergillus fumigatus (click for details) |
|
|
|
Pharmacokinetic Study Of Anidulafungin In Icu Patients With Complicated Intra-abdominal Infection (click for details) |
|
|
|
Intra- and Interlaboratory Study of Antifungal Susceptibility Testing of Isavuconazole against Aspergillus Strains (click for details) |
|
|
